Clinical Trial Update: A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effectiveness of an albuterol multidose dry powder inhaler with an integrated electronic module (eMDPI DS) in participants aged 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) (albuterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2022-10-27